Shares of Sequenom rose 32 percent for the five-day trading week ended Tuesday to lead all stocks in the BCW Index.
 
The gain follows last week’s increase of 23 percent for Sequenom. Last week, the company announced that it had licensed a next-generation sequencing technology from Harvard University.
 
Shares of Cepheid and Bio-Rad Laboratories also had strong weeks, rising 13.5 percent and 13.3 percent, respectively.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.